Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

Host responses to Plasmodium yoelii hepatic stages: a paradigm in host-parasite interaction.

Lau AO, Sacci JB Jr, Azad AF.

J Immunol. 2001 Feb 1;166(3):1945-50.

2.
3.

Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.

Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R.

J Immunol. 2009 Nov 1;183(9):5870-8. doi: 10.4049/jimmunol.0900302. Epub 2009 Oct 7.

5.
6.

The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.

Singh RP, Kashiwamura S, Rao P, Okamura H, Mukherjee A, Chauhan VS.

J Immunol. 2002 May 1;168(9):4674-81.

7.

The complexity of protective immunity against liver-stage malaria.

Doolan DL, Hoffman SL.

J Immunol. 2000 Aug 1;165(3):1453-62.

9.

NK cell responses to Plasmodium infection and control of intrahepatic parasite development.

Roland J, Soulard V, Sellier C, Drapier AM, Di Santo JP, Cazenave PA, Pied S.

J Immunol. 2006 Jul 15;177(2):1229-39.

10.

Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.

Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, Takagi A, Wang R, Kappe SH.

J Infect Dis. 2007 Aug 15;196(4):608-16. Epub 2007 Jul 9.

PMID:
17624848
11.

In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines.

Calvo-Calle JM, Moreno A, Eling WM, Nardin EH.

Exp Parasitol. 1994 Nov;79(3):362-73.

PMID:
7957756
12.

Retrieving parasite specific liver stage gene products in Plasmodium yoelii infected livers using differential display.

Lau AO, Sacci JB Jr, Azad AF.

Mol Biochem Parasitol. 2000 Nov;111(1):143-51.

PMID:
11087924
13.

Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells.

Soulard V, Roland J, Sellier C, Gruner AC, Leite-de-Moraes M, Franetich JF, Rénia L, Cazenave PA, Pied S.

Infect Immun. 2007 May;75(5):2511-22. Epub 2007 Feb 16.

14.

TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6.

Nussler A, Pied S, Goma J, Rénia L, Miltgen F, Grau GE, Mazier D.

Int Immunol. 1991 Apr;3(4):317-21.

PMID:
1878339
17.

Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection.

Ocaña-Morgner C, Wong KA, Lega F, Dotor J, Borras-Cuesta F, Rodriguez A.

Eur J Immunol. 2007 Jun;37(6):1562-74.

18.

Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression.

Sacci JB Jr, Ribeiro JM, Huang F, Alam U, Russell JA, Blair PL, Witney A, Carucci DJ, Azad AF, Aguiar JC.

Mol Biochem Parasitol. 2005 Aug;142(2):177-83. Epub 2005 Apr 26.

PMID:
15876462
19.

Detection of Plasmodium yoelii stage mRNA in BALB/c mice.

Lau AO, Sacci JB Jr, Azad AF.

J Parasitol. 2001 Feb;87(1):19-23.

PMID:
11227890
20.

Genetic control of immunity to Plasmodium yoelii sporozoites.

Weiss WR, Good MF, Hollingdale MR, Miller LH, Berzofsky JA.

J Immunol. 1989 Dec 15;143(12):4263-6.

PMID:
2512354

Supplemental Content

Support Center